About us
Kamuanaku Tissue Technologies (KTT) is a biotechnology company based in Biocant Park, Cantanhede, Portugal, dedicated to advancing regenerative medicine and tissue engineering. We specialize in the development of innovative medical devices and the provision of high-quality in vitro services for academic, clinical, and industrial partners.
Our mission is to create innovative healthcare solutions that promote natural tissue repair, improving patient outcomes and enhancing quality of life.
Our vision is to develop cutting-edge regenerative technologies, creating innovative tissue engineering solutions that empower the body's natural healing processes.
We aim to provide reliable and innovative in vitro testing solutions that help accelerate product development and ensure safety and efficacy.
Through the development and licensing of proprietary technologies, we bring cutting-edge tools to the biotechnology and healthcare industries.
We are committed to building strong partnerships, creating a collaborative network that drives progress in regenerative medicine and tissue engineering.
Innovation: We pursue transformative scientific ideas with practical impact.
Integrity: Ethical research and transparent collaboration are non-negotiable.
Collaboration: We believe in the power of interdisciplinary teamwork.
Sustainability: Environmental and social responsibility guide our operations.
Kamuanaku Tissue Technologies is a sole proprietorship based in Cantanhede, Portugal, focused on advancing regenerative medicine and tissue engineering. Founded by Martinho Francisco, whose passion for healthcare and drive to find innovative solutions to real-world problems inspired the project, the company aims to provide high-quality, innovative solutions that improve health and well-being. KTT supported by a skilled team and cutting-edge technology seeks to earned recognition and success, becoming a trusted reference in its field.